Optiscan Imaging (ASX:OIL) is an Australian medical technology company that develops and commercialises high-resolution optical imaging systems. The company's flagship product is the Optiscan OCT 2000, a non-invasive optical imaging device that is used to diagnose and monitor a range of eye diseases, including glaucoma, diabetic retinopathy, and age-related macular degeneration. Optiscan Imaging is also developing a range of other OCT imaging systems, including a handheld OCT device that is designed for use in point-of-care settings. The company is also developing OCT systems for use in other medical applications, such as cardiology and oncology.